Uwe Reinhardt - Tekla Life Insider

HQL -- USA Stock  

USD 18.82  0.24  1.26%

Independent Trustee

Dr. Uwe E. Reinhardt, Ph.D. is Independent Trustee of HQ Life Sciences Investors. Dr. Reinhardt is the James Madison Professor of Political Economy at Princeton University, teaching economics and public affairs since 1968, and was a member of the Institute of Medicine of the National Academy of Sciences since 1978. He serves on the Audit Committee of each Fund. Dr. Reinhardt is recognized as one of the nation leading authorities on health care economics, a prominent scholar in health care economics and a frequent speaker and author on subjects ranging from the war in Iraq to the future of Medicare. Dr. Reinhardt provides each Fund with valuable insights in healthcare economics and reform. He is a past president of the Association of Health Services Research. From 1986 to 1995 he served as a commissioner on the Physician Payment Review Committee, established in 1986 by Congress to advise it on issues related to the payment of physicians. He is a senior associate of the Judge Institute for Management of Cambridge University, UK, and a trustee of Duke University and the Duke University Health System. Dr. Reinhardt is or was a member of numerous editorial boards, among them the Journal of Health Economics, the Milbank Memorial Quarterly, Health Affairs, the New England Journal of Medicine, and the Journal of the American Medical Association
Age: 79  Executive Since 1992  Ph.D    
617-772-8500  http://www.teklacap.com/hql.html
Reinhardt received his Ph.D. from Yale University.

Management Efficiency

The company has Return on Asset of (0.63) % which means that on every $100 spent on asset it lost $0.63. This is way below average.

Similar Executives

Entity Summary

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Closed-End Fund - Equity classification in USA and traded on New York Stock Exchange.Tekla Life Sciences Investors (HQL) is traded on New York Stock Exchange in USA. It is located in 2 Liberty Square and employs 13 people.

Tekla Life Sciences Leadership Team

William Reardon, Executive, CPA
Michael Bonney, Executive
Oleg Pohotsky, Executive, MBA
Lucinda Stebbins, Executive, CPA
Daniel Omstead, President
Uwe Reinhardt, Executive, Ph.D
Rakesh Jain, Executive

Stock Performance Indicators

Current Sentiment - HQL

Tekla Life Sciences Investor Sentiment
Greater number of Macroaxis users are currently bullish on Tekla Life Sciences Investors. What is your outlook on investing in Tekla Life Sciences Investors? Are you bullish or bearish?
98% Bullish
2% Bearish

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.